Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for iSonea Ltd. (KMLXF : OTC)
 
 • Company Description   
Respiri Limited is involved in the research, development and commercialization of medical devices for asthma, chronic obstructive lung disease and other chronic breathing conditions as well as the production of mobile health applications. Its portfolio of computerized wheeze detection products, including AirSonea, WHolter, SonoSentry, WheezoMeter, PulmoTrack and the AsthmaSense application. Respiri Limited, formerly known as Isonea Limited, is based in Melbourne, Australia.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.05 Daily Weekly Monthly
20 Day Moving Average: 0 shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta: -0.05
52 Week High: $0.08
52 Week Low: $0.04
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% 9.16%
12 Week -19.97% -13.50%
Year To Date -19.97% -5.20%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10/446 Collins Street
-
Melbourne,VI 3000
AUS
ph: 61 -0-3 9602 3366
fax: 61 -0-3 9602 3606
None http://www.respiri.co
 
 • General Corporate Information   
Officers
Mario Gattino - Chief Executive Officer and Director
Koswani Wall - Chief Customer Experience & Communications Officer
Samaneh Sarraf Shirazi - Chief Research Officer
Jan P. Barker - Vice President
Alastair Beard - Secretary

Peer Information
iSonea Ltd. (ABMD)
iSonea Ltd. (DMDS)
iSonea Ltd. (CPWY.)
iSonea Ltd. (EQUR)
iSonea Ltd. (ECIA)
iSonea Ltd. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: Q8124J104
SIC: 8880
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding:
Most Recent Split Date: 7.00 (0.05:1)
Beta: -0.05
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©